Verified earnings results
Regeneron Pharmaceuticals Q3 2026 Earnings Results
Direct answer
Regeneron Pharmaceuticals reported Q3 2026 results on October 30, 2026.
Revenue was 5,115,800,000. EPS beat the estimate by 21.18%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- October 30, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- 16.5625
- Reported EPS
- 20.07
- Revenue
- 5,115,800,000
- EPS surprise
- EPS beat the estimate by 21.18%.
Explore related company data
Read the frequently asked questions.
When did Regeneron Pharmaceuticals report Q3 2026 earnings?
Regeneron Pharmaceuticals reported on October 30, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Regeneron Pharmaceuticals?
The verified record provides an EPS estimate of 16.5625.
Has Regeneron Pharmaceuticals reported the Q3 2026 result?
Revenue was 5,115,800,000. EPS beat the estimate by 21.18%.
Which source supports this Regeneron Pharmaceuticals earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.